Behavioral therapy improves supragastric belching and depression, finds study
Supragastric belching (SGB) is considered a behavioural disorder. SGB can manifest as a large number of belch episodes during daytime, or can be associated with reflux symptoms or rumination. Supragastric belches can be immediately followed by acid reflux and in some GORD patients, SGB-associated reflux can contribute to up to 1/3 of the total acid exposure (AET). Current treatments for...
Supragastric belching (SGB) is considered a behavioural disorder. SGB can manifest as a large number of belch episodes during daytime, or can be associated with reflux symptoms or rumination. Supragastric belches can be immediately followed by acid reflux and in some GORD patients, SGB-associated reflux can contribute to up to 1/3 of the total acid exposure (AET). Current treatments for SGB are cognitive behavioural therapy (CBT) and medications like Baclofen.
Recent research has suggested that behavioral therapy is superior to follow-up without intervention in patients with supragastric belching in reducing belching and depression; it also improves mental well-being but has only a modest effect on anxiety and health-related quality of life. The findings have been put forth in Neurogastroenterology and Motility.
Behavioral therapy (BT) has been proven effective in the treatment of supragastric belching (SGB) in open studies. It is also documented that excessive supragastric belching (SGB) manifests as troublesome belching, and can be associated with reflux and significant impact on quality of life (QOL); whereas Cognitive behavioral therapy reduced the number of SGB and improved social and daily activities. The aim of the current study was to compare BT to follow-up without intervention in patients with SGB in a randomized study.
In a trial designed at the Department of Gastroenterology, Helsinki University Hospital, Helsinki, Finland, forty-two patients were randomized to receive 5 sessions of BT, comprising diaphragmatic breathing exercises, or to follow-up without intervention. Patients were evaluated at 6 months, at which point the control group was also offered BT and evaluated after another 6 months. The frequency and intensity of belching and mental well-being were evaluated with a visual analog scale (VAS). Depression, anxiety, and health-related quality of life (HRQoL) were evaluated with four questionnaires: BDI, BAI, 15D, and RAND-36.
Key results have been summarized below.
- The frequency and intensity of SGB were significantly lower in the therapy group (n = 19) than in the control group (n = 18) at the 6-month control (p < 0.001).
- When all patients (n = 36) were evaluated 6 months after BT, in addition to relief in the frequency and intensity of belching (p < 0.001), mental well-being had also improved (p < 0.05). Of all 36 patients, 27(75%) responded to BT.
- Depression scores were lower after therapy (p < 0.05). Only minor changes occurred in anxiety and HRQoL.
For full article follow he link: DOI: 10.1111/nmo.14171
Source: Neurogastroenterology and Motility
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd